You are here: Industry Insights > AZSTARYS

News List

KemPharm Receives $10M Milestone Payment for FDA Approval of AZSTARYS™ americanpharmaceuticalreview
April 23, 2021
KemPharm, Inc. has announced receipt of a regulatory milestone payment of $10 million for the FDA approval of AZSTARYS™ in accordance with the recently amended definitive collaboration and license agreement with Commave Therapeutics, SA, an affiliate ...
KemPharm Receives $10M Milestone for FDA Approval of Azstarys contractpharma
April 23, 2021
KemPharm Inc., a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, has confirmed receipt of a regulatory milestone payment of $10 million for the FDA approval of Azstarys in accordance with the recently ...
KemPharm Announces FDA Approval of AZSTARYS for ADHD americanpharmaceuticalreview
March 08, 2021
KemPharm has announced the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for (NDA) AZSTARYS™ (formerly referred to as KP415), a once-daily product for the treatment of attention deficit hyperactivity disorder (ADHD) in ...